Elevance Health Expects Higher Revenue, Profit in 2025
4 days ago · The top-line gain was driven by higher premium yields in Elevance's health benefits business, acquisitions completed during the year and growth in product revenue from pharmacy benefits manager ...
Elevance Health Buy Rating: Growth Potential Despite Cost …
23 hours ago · Despite encountering elevated cost trends in Medicaid, Elevance Health anticipates improvement in the second half of 2025, with significant rate updates expected in July.
Is Elevance Health Stock Underperforming the Dow? - Nasdaq
Dec 6, 2024 · Despite observing a steep decline in prices and underperforming the Dow Jones Industrial Average over the past year, analysts remain strongly bullish on Elevance Health’s prospects.
Elevance Health Reports Fourth Quarter and Full Year 2024
5 days ago · Quarterly dividend increased by 5% to $1.71 per share Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2024 results.
Health Care Up as Elevance Rises on Earnings - Morningstar
5 days ago · Health-care companies rose sharply amid strong earnings. Elevance Health, the health insurer formerly known as Anthem, posted fourth-quarter profit and revenue ahead of Wall Street targets, and ...
Elevance Health Inc. stock outperforms competitors despite …
Dec 17, 2024 · Shares of Elevance Health Inc. ELV shed 1.88% to $366.30 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.39% to...
Elevance Health Inc. stock rises Tuesday, still ... - MarketWatch
Shares of Elevance Health Inc. ELV inched 0.55% higher to $372.94 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising...
Elevance Health Inc (ELV) Stock Price & News - Google Finance
Get the latest Elevance Health Inc (ELV) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Elevance Health's Profit Plunges 50%, But Shares Jump 2.2% on …
4 days ago · The big question: Can Elevance keep costs in check while leveraging premium hikes, acquisitions, and Carelon's expansion? The long-term play looks solid, but short-term turbulence is far from over.
Cautious Hold Recommendation on Elevance Health Amidst …
4 days ago · Joanna Gajuk, an analyst from Bank of America Securities, reiterated the Hold rating on Elevance Health (ELV – Research Report). The associated price target is $465.00. Joanna Gajuk’s rating ...
- Some results have been removed